PTAB challenges

Proceedings overview

As of the current date, U.S. Patent 8,677,398 has been the subject of one AIA trial proceeding, IPR2025-01317, which resulted in a discretionary denial of institution. This means the patent's claims have not been formally challenged on the merits at the PTAB in this particular proceeding, and the patent's validity remains undiminished by this IPR. For a defendant, this indicates that an IPR-based defense targeting the grounds raised in IPR2025-01317 would face the hurdle of overcoming the Board's prior discretionary denial.

IPR2025-01317 — LiveIntent, Inc. v. Intent IQ LLC

• Type: Inter Partes Review
• Filed: 2025-07-18
• Status: Discretionary Denial. The PTAB declined to institute the inter partes review on procedural grounds.
• Judge panel: Information regarding the specific judge panel for this proceeding is not readily available in public summaries for discretionary denials, but generally includes a panel of three Administrative Patent Judges.
• Petition grounds: Specific details of the claims challenged, prior art asserted, and statutory bases (§ 102 / § 103) are typically elaborated in the petition and institution decision. Given the discretionary denial, a full analysis of these grounds by the Board on the merits did not occur.
• Institution decision: Denied. The institution was procedurally denied on 2026-01-12. The PTAB issued a decision denying institution, often due to factors such as parallel district court litigation, arguments under Fintiv factors, or other procedural considerations, rather than on the merits of the prior art.
• Final Written Decision: Not issued, as institution was denied.
• Settlement / termination: Not applicable, as the proceeding was terminated by a denial of institution.
• Appeal: There is no public record of an appeal to the Federal Circuit for this discretionary denial.
• Defensive value: This proceeding indicates that LiveIntent, Inc. attempted an IPR challenge, but it was not instituted on the merits. A future defendant, especially one in privity with LiveIntent, Inc., would be estopped from raising the same or reasonably could have raised grounds in a subsequent IPR. For other defendants, while the Board did not rule on the merits of patentability, the discretionary denial might signal a strategic challenge in instituting an IPR against this patent, potentially requiring different grounds or a different procedural posture.

Strategic summary

Only one AIA trial proceeding, IPR2025-01317, is listed as on file for U.S. Patent 8,677,398, and it resulted in a discretionary denial of institution. This means that, based on the provided canonical list, all claims (1-15, as granted) of US Patent 8,677,398 remain UNTESTED by a formal PTAB review on the merits. No claims have been canceled or formally sustained by a Final Written Decision in an IPR proceeding.

The estoppel landscape from IPR2025-01317 would apply to LiveIntent, Inc. (the petitioner) and its privies. Under 35 U.S.C. § 315(e)(2), they would be barred from asserting in future civil actions or other USPTO proceedings any ground that was raised or reasonably could have been raised in this IPR. For other potential defendants, this specific IPR denial does not directly impose estoppel on new challenges, though it might highlight the PTAB's current stance on discretionary denials.

The litigation history indicates that Intent IQ LLC (and its affiliates) are actively asserting this patent against numerous major technology and media companies, including district court cases and other IPRs (IPR2022-00773, IPR2022-00883, IPR2017-01299 mentioned in the background but not in the canonical list for this task). The fact that IPR2025-01317 was denied institution suggests that the patent owner has successfully defended against at least one PTAB challenge, possibly on procedural grounds related to parallel litigation or other discretionary factors, rather than a lack of merit in the prior art itself.

Recommended next steps

Given that IPR2025-01317 resulted in a discretionary denial, there is no Final Written Decision to link to or quote regarding claim invalidation.

For any defendant facing assertion of US Patent 8,677,398, it is critical to:

• Review the institution decision for IPR2025-01317: Obtain and thoroughly analyze the PTAB's written decision denying institution for IPR2025-01317. This document, publicly available via the USPTO PTAB E2E system (https://e2e.uspto.gov/e2e/patents), will outline the specific reasons for the discretionary denial. Understanding these reasons is crucial for assessing the viability of future IPR petitions.
• Assess the other IPRs mentioned in the litigation summary: While not included in the canonical PTAB proceedings on file for this specific task, the litigation summary explicitly mentions other IPRs (IPR2022-00773, IPR2022-00883, IPR2017-01299) related to US8677398. It is imperative to investigate the outcomes of these cases, particularly IPR2022-00883, which was instituted, to determine if any claims were invalidated or upheld on the merits in those proceedings. This would provide a more complete picture of the patent's validity and the claims that have survived scrutiny.
• Conduct independent prior art search: Given the active litigation and the lack of a merits-based PTAB decision on record for IPR2025-01317, a thorough, independent prior art search is advisable to identify strong non-cumulative art that could support new invalidity arguments in a fresh IPR or district court defense.
• Evaluate estoppel implications: If the defendant is in any way related to LiveIntent, Inc., a careful analysis of the estoppel implications from IPR2025-01317 is necessary before pursuing any IPR.
• Monitor for new PTAB filings: Continuously monitor the PTAB E2E system for any new IPR, PGR, or CBM petitions filed against US Patent 8,677,398. New proceedings could alter the defensive landscape rapidly.